Abstract
A review of the possible reasons to measure quality of life in cancer patients as well as reasons not to measure it is presented. These are considered in the context that standard endpoints already exist in cancer clinical trials and have served us well. Quality-of-life assessments might best be utilized in trials in which survival differences between treatments are expected to be small, which is frequently the case. Although more data are required to establish properly the true value of quality-of-life measurement in cancer clinical trials, such measurements should be encouraged.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cella DF, Tuslky DS (1993) Quality of life in cancer. Definition, purpose and method of measurement. Cancer Invest 11:327–336
Coates A (1993) Prognostic implications of quality of life. Cancer Treat Rev 19 [Suppl A]:53–57
Coates A, Gebski V, Bishop JF, et al (1987) Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies. N Engl J Med 317:1490–1495
Drummond MF, Stoddard GL, Torrance GW (1987) Methods for economic evaluation of health care programs. Oxford Medical Publications, Oxford
Ganz PA, Haskell CM, Figlin R, La-Sota N, Siau I (1989) Estimating the quality of life in a clinical trial of patients with metastatic lung cancer using the Karnofsky performance status and the Functional Living Index — Cancer. Cancer 61:849–856
Gelber RD, Cole BF, Goldhirsch A, for the International Breast Cancer Study Group, Bern, Switzerland (1993) How to compare quality of life of breast cancer patients in clinical trials. Recent Results Cancer Res 127:221–233
Gotay CC, Korn EL, McCabe MS, Moore TD, Cheson BD (1992) Quality of life assessment in cancer treatment protocols: research issues in protocol development. J Natl Cancer Inst 84:575–579
Kaplan RM (1993) Quality of life assessment for cost/utility studies in cancer. Cancer Treat Rev 19 [Suppl A]:85–96
Osoba D (1991) Measuring the effect of cancer on quality of life. In: Osoba D (ed) Effect of cancer on quality of life. CRC, Boca Raton, Fla, pp 25–40
Schipper H (1990) Guidelines and caveats for quality of life measurements in clinical practice and research. Oncology 4:51–57
Shumaker SA, Anderson RT, Czajkowski SM (1990) Psychology tests and scales. In: Spilker B (ed) Quality of life assessments in clinical trials. Raven Press, New York, pp 95–113
Sugarbaker PH, Barofsky I, Rosenberg SA, Gianola FJ (1982) Quality of life assessment of patients in extremity sarcoma trials. Surgery 91:17–23
Till JE, McNeil BJ, Bush RS (1984) Measurements of multiple components of quality of life. Cancer Treat Sympt 1:177
Till JE, Sutherland HJ, Meslin EM (1992) Is there a role for preference assessments in research on quality of life in oncology? Quality of Life Res 1:31–40
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Feld, R. Endpoints in cancer clinical trials: is there a need for measuring quality of life?. Support Care Cancer 3, 23–27 (1995). https://doi.org/10.1007/BF00343917
Issue Date:
DOI: https://doi.org/10.1007/BF00343917